• Friendable completed the acquisition of Artist Republik on January 4, 2022, with the Form 8-K filed with the SEC on January 10 offering an overview of that transaction
• The acquisition of Artist Republik in conjunction with Friendable’s flagship product Fan Pass Live artist platform allows for independent artists to create, perform, produce, and distribute their music without private representation
• President and CTO Dean Rositano was recently invited to join the Rolling Stone Culture Council, an invitation-only opportunity that sheds an additional positive light on the company within the music industry

One of the first reports in 2022 from Friendable (OTC: FDBL), a mobile technology and marketing company focused on identifying products, services, and brand opportunities with mass-market potential and scalability, was the successful acquisition of music production, distribution, marketing, and management platform Artist Republik on January 4. The acquisition covers all of Artist Republik’s revenue, customers, back-end processes, trademarks, internet domains and other aspects necessary to carry on the business. Friendable also entered into a consulting agreement with Artist Republik’s founder, Nick Cianfaglione. The entire Asset Purchase Agreement can be found as an Exhibit with the company’s SEC 8-K filing from December 23, 2021. Artist Republik is a subscription service designed to allow artists worldwide to take control of their music careers through networking, centralized sources, and AI-based management tools. By adding Artist Republik’s platform to Friendable’s flagship product, Fan Pass Live, the company has effectively made it possible for independent artists to manage their careers from production to performance to distribution. Artists will now be able to distribute their music on streaming platforms, receive royalties from these platforms, and create a marketplace where users can purchase beats, enhance audio production, and purchase access to curated playlists. By acquiring Artist Republik, Friendable, and the Fan Pass Live artist platform are now able to offer new skillsets and benefits to artist members (https://ibn.fm/ZrP5W), including:

• Distribution (one-time or subscription-based) – Artists can now release their music on all major streaming platforms
• Press release promotion – Submit a draft for a blog outlet post on the artist’s page
• Spotify playlisting – Submit your playlist to curators to grow artist streaming
• Elite reviews – Artists can receive feedback on their music from notable industry artists
• Custom ARTSTLNKS – A single link where artists can promote their music, merchandise, shows, and anything else they want
• Instagram promotion – Artists can grow their audience on social media by submitting their content for placed promotion
• ‘Grow with us’ features – Spotify and Soundcloud growth marketing
• Mastering – Artists can get songs mixed and/or mastered
• Sound store – Artists can purchase or sell sounds, beats, sample packs, and more
• FeaturedX – Artists book a guest feature, co-write, midi composition, or live instrumental tracking for their next single. FeaturedX is a service that requires artists to sign up to be an artist/creator on the platform
• Biz resources – Blog promotion management, playlist curation, Instagram curation, elite reviewer, and audio engineer.

The acquisition will help Friendable expand its reach into the music distribution space, a growing market worldwide. In 2020, the global music distribution services sector was valued at $911.87 million, and it is expected to grow at a CAGR of 6.2%, resulting in a market value of $1683.08 million by 2030 (https://ibn.fm/8H0Vj). A substantial part of this growth is attributed to the need for online music distribution during the pandemic – the market was able to integrate new ways of monetizing music consumption during this time, circumventing the negative impacts other markets felt. Since its launch in July 2020, Fan Pass Live has become a major player in the artist streaming world, driven by its unique business model and the unrelentless passion of brothers Robert A. Rositano, Jr. (“CEO”) and Dean Rositano (President and CTO) for artists and their music. Dean Rositano was recently selected to be a part of the Rolling Stone Culture Council – an invitation-only network of leaders on the cutting edge of what’s new in culture, community, and all things associated with the Rolling Stone brand. The move can further strengthen Friendable’s visibility and reach in the market. “Having been a touring musician in my teenage years and continuing to play music as my hobby, the Rolling Stone brand has always been something I have admired, followed, and truly coveted as an industry staple,” Dean Rositano said, describing the experience (https://ibn.fm/jaD4g). “Now to be a part of a community that identifies with this very brand, while being a founding member and CTO of Fan Pass Live, it’s kind of unbelievable to see my name associated with Rolling Stone, but it’s amazing and exciting to have such an opportunity that aligns with everything we have developed and what we are all about, supporting music artists.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clients
• Company deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North America
• Company actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified health and wellness beverage and natural products company developing and manufacturing a diverse portfolio of alkaline, plant-based, and cannabinoid beverages and supplements for in-house brands and white-label clients alike. Founded in 2017, BevCanna was quick to leverage a unique value that its team of established beverage experts brings to the table – deep knowledge of consumer preferences and buying behavior that inspires the creation of products that appeal to consumers at a mass scale. Committed to promoting wellbeing and quality of life through products it creates, the Company sees an opportunity in the infused beverages market as consumers seek new products that are aligned with a more health-conscious lifestyle. ReportLinker, an AI-driven market intelligence company, finds that the global cannabis beverages market is expected to reach US$2 billion by 2026. The US segment, where CBD-infused beverages are gaining popularity as they are becoming readily available through mainstream retail outlets, is estimated at US$649.1 million in 2021, accounting for a 70.9% share in the global market. According to the report, the changing legal status, growing societal acceptance, and increasing awareness of CBD benefits are attracting more and more food and drink companies to this burgeoning market as demand and sales grow (https://ibn.fm/pQCz9). With an innovation-focused approach, BevCanna itself employs an in-house brand and white label beverage manufacturing model in the cannabis beverage arena with distribution in regulated retail and online sales channels. Naturo Group (wholly owned subsidiary) employs an in-house brand and white label beverage manufacturing model in the CPG (traditional beverage + Natural product) arena with distribution in traditional retail and online sales. Pure Therapy (wholly owned subsidiary) employs a direct-to-consumer e-commerce model to sell natural health products, including nutraceutical and plant-based products across North America. With decades-long experience commercializing innovative products, the BevCanna team has a track record of developing highly customizable products, such as wellness and recreational beverages, that are targeted to various markets, including value, craft, and premium. Committed to building a lasting business and establishing dominance in the product category, BevCanna remains open to acquisitions, joint venture opportunities, and strategic partnerships. The Company appears confident that there exists a vast room for growth as consumers are just starting to explore opportunities within this dynamic product category. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• GreenBox POS is an advanced blockchain technology payment solutions provider focused on expanding its FinTech portfolio through strategic acquisitions in the United States and internationally
• The company acquired key assets during 2021 that demonstrate its commitment to expand its balance payment solutions for point-of-sale retail as well as e-commerce opportunities
• GreenBox announced this month that it has reached a binding agreement to acquire a licensed payment institution in the United Kingdom to further its debit and credit card payment processing abilities
• One of the company’s subsidiaries, ChargeSavvy, further highlighted the success of GreenBox’s strategy by announcing that it recorded a record 166 percent increase in its retail division’s book of business during the fourth quarter
• GreenBox has increased its funding options for repurchasing its common shares as a boon to shareholders and a display of the company’s confidence in its opportunities for 2022

Proprietary blockchain security and token technology-focused FinTech company GreenBox POS (NASDAQ: GBOX) is entering 2022 with expectations for another breakout year for customized payment solutions following successful bank and acquisition building campaigns during recent months. “Strategic acquisitions are already slated for 2022, so you all can expect to see a lot more of that in the year to come,” GreenBox’s Chief Operating Officer Vanessa Luna told investors during a corporate update call Dec. 9 (https://ibn.fm/fRMqX). “We’ll continue expanding our licensing and broadening our network and processing capabilities.” “Accumulating an array of technologies is vital to our long-term growth strategy, as GreenBox further progresses toward global expansion,” Chief Business Development Officer Pouya Moghavem stated. GreenBox’s July acquisition of point-of-sale company ChargeSavvy was GreenBox’s first major purchase that entailed an integration of the team, culture and operations of its new subsidiary, and the transaction granted ChargeSavvy a strong merchant client portfolio and point of sale technology, poising the division to grow into new categories where the same technology can be applied. Subsequently, ChargeSavvy recorded an average 166 percent increase YOY in its retail division’s book of business during the fourth quarter of 2021 — the best quarter in its nine-year history, according to the company (https://ibn.fm/mKQ3H). GreenBox is working to strengthening its standing with Visa and Signature Bank by establishing a well-balanced portfolio between point-of-sale retailers and e-commerce, onboarding low-risk merchants and eventually more high-margin clients, Luna and President of Global Payments Ken Haller told GreenBox’s investors during the December update call. That will in turn create opportunities for monetization through NFTs, card issuing, bank as a service, and blockchain closed loop systems. “Earlier in the year we purchased a payment processing company in Boston, allowing us to place merchant accounts on our own BIN. BIN is a high-level license in the U.S. that gives us great control and flexibility in onboarding merchants,” Haller said. Luna highlighted an exclusive joint venture in American Samoa that serves as a model market for FinTech payment solutions for island-type ecosystems around the world. As further evidence of GreenBox’s self-assurance in its growth strategy and pending opportunities, the company announced Jan. 6 a “substantial increase in the funds allocated for the immediate repurchase of the Company’s common shares, in the initial sum of $10M” (https://ibn.fm/V2drr). The company previously repurchased about 800,000 shares during the second half of 2021. For more information, visit the company’s website at www.GreenBoxPOS.com. NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

• Hollywall Entertainment Inc. is a technology and broadcasting company using an enormous variety of resources under its corporate umbrella to extend wireless and broadband networks and related services across the country
• Hollywall is dedicated to extending its networks to underserved or unserved communities, with a vision of improving access to technology and thereby improving socio-economic equality for opportunities and achievements
• The company’s holdings include the rights to a catalog of over 17,500 master recordings performed by music legends ranging from Ray Charles to Rod Stewart
• The music catalog is also being used as a means of entering the blockchain NFT space, which has enjoyed an astronomical rise in market cap during the past couple years, monetizing digital ownership of featured art

Former NBA All-Star point guard and pro basketball coach Lionel Hollins, whose most recent professional victory was as assistant coach with the Los Angeles Lakers in 2020 when he won an NBA championship ring for the second time, climbed the ladder of success from a childhood in Las Vegas where all his clothes were patched and oversized, and he was “a vegetarian before it was in vogue” out of simple necessity, as he told The Spectrum a few years earlier. Perhaps a testament to the theory that education is the great socio-economic equalizer, particularly when it included “cross-class friendships” that bridge social strata through ordinary peer exchanges to create achievement equity (https://ibn.fm/ZHzxn), Hollins left a neighborhood where “white people didn’t exist” to attend junior college at Dixie College in Southern Utah, about 120 miles away, where he “was the only black person on the basketball team … the only black person at the college … the only black in the city,” thus beginning a storied career driven by his ambition and the help of others who mentored him, he told the newspaper (https://ibn.fm/jqJyQ). It’s the type of story that resonates in harmony with the vision of the telecommunications and broadcasting company Hollywall Entertainment (OTC: HWAL), which is using a vast catalog of music, film, television, software and game library rights to not only build smart city, fiber network and entertainment investment profits throughout the United States, but to also create broadband access equity for many of the nation’s most vulnerable and underserved communities. “There is some evidence that broadband initiatives for unserved and underserved areas increase broadband adoption and can increase labor market participation, with larger effects for people living in rural areas and for women, especially those with college educations,” The University of Wisconsin’s County Health Rankings & Roadmaps program noted last year (https://ibn.fm/GAI50). “The rich nations must use their vast resources of wealth to develop the underdeveloped, school the unschooled, and feed the unfed,” HWAL President and CEO Darnell Sutton has stated in repeating civil rights pioneer the Rev. Martin Luther King’s 1964 Nobel Peace Prize lecture (https://ibn.fm/BvJmH). “Let us heed to this time-honored clarion call, as the challenge yet remains for all to consider coming together and embrace one another in peaceful cooperation … allowing our newfound cooperation to shine a bright light on a new path for a coming and future brilliant generation.” Hollywall’s asset portfolio includes copyrights, legal rights, trademarks, and master recordings of more than 17,500 songs, with a library of artists that includes Elvis Presley, Michael Jackson, Dolly Parton, Frank Sinatra, and The Who. Through its new wholly owned subsidiary, HW Vision, the company offers state-of-the-art services such as 5G and fiber network installation, affordable high-speed internet access, telehealth, nationwide unlimited talk, text and data cellphone plans, and video broadcasting. As a company deeply invested in telecom infrastructure, Hollywall is well positioned to capitalize on the expanding 5G infrastructure market as wireless networks evolve in the United States (https://ibn.fm/JTCGX). 5G-speed networks will better facilitate Hollywall’s key telecom initiatives, such as fostering entrepreneurial and economic development opportunities for minority business enterprises (“MBEs”) through rural and urban wireless and broadband telecommunications network infrastructure, and also helping farmers maintain and increase sustainable practices using digital tools in agriculturally rich rural areas. Hollywall is also using its music catalog to enter the world of blockchain technology and non-fungible tokens (“NFTs”), which has a market cap of about $31.4 billion, according to a recent report by Blockworks (https://ibn.fm/cpnJV) rising astronomically from about $80 million just a couple years ago (https://ibn.fm/3rrJA). For more information, visit the company’s website at www.Hollywall.com. NOTE TO INVESTORS: The latest news and updates relating to HWAL are available in the company’s newsroom at https://ibn.fm/HWAL

• Canadian-based mental health treatment-focused biotechnology company Mydecine Innovations Group has been advancing research on the use and improvement of compounds found in nature, particularly the psychedelic psilocybin compound
• Mydecine recently announced an LOI with The Newly Institute to use Mydecine’s psilocybin and MDMA for treatment at The Newly’s mental health clinics nationwide
• The LOI is the first collaboration under Mydecine’s SASSP program, which will provide psychedelic drug products and related services to physicians, clinics and hospitals in Canada for psychotherapy
• Health Canada announced earlier this month that the government has amended its medicinal regulations to allow psilocybin and MDMA prescriptions for otherwise treatment-resistant patients

Addiction and mental health treatment-focused biotechnology company Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) is building on its psychedelics-as-a-medicine research through a collaborative partnership LOI that would see Mydecine supply two psychedelic drug compounds for mental health treatments in compliance with the standards for Health Canada’s Special Access Program (“SAP”). The partnership LOI between Mydecine and The Newly Institute Inc. aims to provide more effective responses to psychotherapy patients at The Newly’s private inter-disciplinary mental health clinics across Canada, with a proposed revenue-sharing agreement between the two companies. Under the rubric of the program, Mydecine will provide cGMP (Current Good Manufacturing Practice-adherent) psilocybin and 3,4-methylenedioxymethamphetamine (known commonly as MDMA, or Ecstasy) along with safety and efficacy data required by the SAP. The Newly will provide the clinic locations and their experienced therapists for the treatments. “Research supports that psychedelic-assisted psychotherapy can break down deeply rooted psychological defenses, facilitate therapeutic breakthroughs and effect substantial improvements in long-term mental health,” The Newly Chief Scientific Officer Dr. Marshall Ross stated in a news release announcing the LOI (https://ibn.fm/7q7zP). “Our goal at The Newly is to build a network of clinics across Canada that deliver innovative and leading-edge mental health treatments to individuals in need,” The Newly President & CEO Arthur H. Kwan added. “The platform we’re developing can be very effective in enabling us to deploy new and innovative best-practice treatments and therapies. We are pleased to partner with a company like Mydecine to enhance the mental health care being provided to Canadians.” The partnership is the first to be announced under Mydecine’s Special Access Support and Supply Program (“SASSP”), which will provide psychedelic drug products and related services to physicians, clinics and hospitals in Canada for psychotherapy (https://ibn.fm/f9Dpl) in the wake of Health Canada’s announcement that federal regulations have been amended to allow caregivers and pharmacists to obtain and prescribe psilocybin and MDMA for treatment-resistant patients (https://ibn.fm/VDTtd). Mydecine and The Newly will work together to develop the protocols for treatment and therapy manuals for a variety of conditions. As a company committed to research, development and acceptance of alternative nature-sourced medicine for mainstream use, Mydecine has conducted significant research on the pharmacological potential in mushrooms, discovering dozens of compounds in varied mushroom species — a large majority of which appear to have never been reported before. “Most of these compounds are evolved to protect the mushroom’s fruiting body from predation by insects, nematodes and bacteria and are complex and metabolically expensive to produce. Since these compounds are evolved to affect biological systems and aspects of metabolic pathways, they stand a higher chance of proving to be useful pharmaceuticals,” the company’s Senior Scientist Duff Sloley stated last year (https://ibn.fm/mI0ab). A major area of focus for the company’s research has related to treating nicotine-addicted patients in the United States to help them quit smoking (https://ibn.fm/GIPzx), with a proposed FDA-approved study set to launch in the next couple months (https://ibn.fm/QlRsN). For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives, vape products, energy boost, and dietary supplements, to name. Products in the alternative category comprise products that are disrupting the traditional products; they are either substitutes for better-known products or there are no substitutes for them in the mainstream category. Exhibitors can showcase their products at dedicated booths and opt for sponsorships to conduct advertising to drive traffic to their booths wherein they impart extensive information regarding their products and services. There will also be several show specials to offer discounts on wholesale pricing for store owners. The products/services can be exhibited under the following Industry types: Accessories (Glass, Rolling papers, etc), Cannabis and cannabis derivatives such as CBD, hemp, delta8 and more, Dietary supplements, functional beverages, herbal products, kratom, mushrooms, nicotine replacements, nootropic, psychedelics, service providers, vape, and others. Thought leaders at the event will discuss vital topics and share valuable information about the latest market trends of the growing alternative product ecosystem. The conference offers a huge arena for joint venture collaborations and gives attendees direct access to connect with worldwide cannabis industry leaders who share their vision about the future scope of these products. The Alternative Products Expo includes keynotes, discussions, and workshops from eminent industry personas who will share important insights and education about the latest trends in the alternative products ecosystem. This event is a suitable platform for new businesses and traders to explore and discover long-term business opportunities in this niche. The participants can enroll as a speaker at The Alternative Products Expo. The influential speaking faculty includes an impressive lineup of industry thinkers, professionals, and executives who have immense knowledge and experience in the alternative products field which they will share with the attendees of the conference. With the growing inclination towards the alternative products category, vendors, and new businesses can connect with established traders and build long-term ties that are beneficial for the success of their company. For more information, please visit https://altproexpo.com/.

• Pluaris automates reading and analysis of textual data
• The app puts the power of data science into the hands of a wide range of consumers
• The platform is designed to help users who need to learn the most in the least amount of time

Knowledge workers, lifelong learners and teams and enterprises all stand to benefit from Nowigence’s Inc. (NOWG) focus on simplifying the challenges of learning. Recognizing the increasing demand for a quick, accessible solution to the overwhelming amount of information available in today’s world, the company created Pluaris(TM). The cloud-based app automates reading and analysis of textual data so users can learn more in less time, uncover hidden insights, and stay on top of the information they need to know. Pluaris integrates state-of-the-art data-processing techniques in an intuitive interface that puts the power of data science into the hands of a wide range of consumers. Nowigence has shared several user-success stories, showing the app’s diverse power and appeal (https://ibn.fm/PMScd). For knowledge workers who need to learn the most in the least amount of time, Pluaris automatically retrieves and analyzes publicly available reports, news and analysis on selected topics of interest every day. Users can then scroll through an annotated news feed on their phones, tablets or laptop whenever it is most convenient. “A Pluaris enterprise customer was interested in tracking news and events in the telecom industry,” the company reported. “The customer was able to quickly create and then fine-tune a list of topics to monitor. In just two days, she had an annotated news feed covering the telecom industry available for her whole team.” Another customer was already using Pluaris for business reasons when he decided to focus on improving his health, so he turned to Pluaris on a personal level. He uploaded research reports to Pluaris, read through the summaries and explored the annotated labels. He then set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.” The company reported that from those results, the Pluaris user built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level down. As for enterprise users, Nowigence shared the instance of a Pluaris user at one of the world’s largest aluminum-mining companies whose manager had assigned her to prepare talking points for an upcoming investor meeting. “Using Pluaris, she had over time built a database of documents, including transcripts, notes, Q&A sessions, speeches and internal documents, some of which were from previous investor meetings,” the company stated. “She was able to quickly explore that knowledge base through the Pluaris Dashboard, drilling down using various filters. She quickly pulled this information together in a Pluaris Notebook and shared the note directly with her boss.” The ways to use Pluaris are almost unlimited, and the SaaS platform is flexible, accessible and affordable. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits
• InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids
• As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market
• The company plans to launch new rare cannabinoid products in the first half of 2022

The human body naturally produces cannabinoids – endocannabinoids such as anandamide (“ANA”) – as part of a physiologic system that maintains human health by reducing inflammation and promoting homeostasis (https://ibn.fm/TavdM). So named after the plant that led to its discovery, the endocannabinoid system (“ECS”) however only produces two known cannabinoid compounds, while over 140 variants can be found in the cannabis plant, most in trace amounts. Of the latter group of cannabinoids, cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) are the most common. Researchers have in fact studied both of them for decades, with studies showing that THC is the primary active ingredient in cannabis, followed by CBD. “Although CBD and THC make up most of the content in cannabis plants, they are not the only compounds that matter. The plants also have many rare cannabinoids with potential health and manufacturing uses that can now be studied,” a 2021 Forbes article reads (https://ibn.fm/J50nM). Studies now suggest that these “rare cannabinoids” could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. However, unlike the abundant THC and CBD products already covering the marketplace, rare cannabinoids are extremely difficult to extract from the cannabis plant and have therefore not been looked at more closely to ascertain their medical benefits. In understanding the immense potential of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates as well as manufacturing and delivering high-quality rare cannabinoids for a variety of uses, sees these rare cannabinoids as having applications as wide as CBD and THC. This is a hot topic in the industry. However, the industry-wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. The answer is to develop and apply successful large-scale bio-synthesis capabilities, technologies that are complex and not readily available for these rare compounds. In October, the company celebrated a huge milestone that cemented its status as a leader in this rapidly developing field. It completed the acquisition of Bay Medica, a U.S.-based private company that specializes in the development of large-scale manufacturing and commercialization of rare cannabinoids (https://ibn.fm/RZaFE). The company has amassed an unmatched talent pool of large-scale synthetic production expertise from the industry that can be applied to rare cannabinoids. The acquisition complements InMed’s efforts within the pharmaceutical industry by adding BayMedica’s synthetic biology and chemical synthesis capabilities and expertise, in what would provide InMed with complete rare cannabinoid manufacturing flexibility to select the most appropriate, cost-effective method based on the target cannabinoid and applicable quality specifications for the desired industry. “[BayMedica has] been deploying different manufacturing techniques such as chemical synthesis, yeast biosynthesis, and InMed has not only bacterial biosynthesis but also a new approach called enzymatic biotransformation – our IntegraSyn(TM) system,” stated InMed CEO Eric A. Adams during the 2022 Edison Open House Global Healthcare Conference held on January 25 (https://ibn.fm/cLV9z). “I think we are the only company out there that can offer a full slate of these different manufacturing technologies. That’s important because no one technology is best for the whole spectrum of different cannabinoids… So, we are now in a unique position to pick and choose whatever the lowest cost manufacturing technology is for any one of these different cannabinoids,” added Adams. InMed believes it is currently the leader in large batch production of the rare cannabinoid cannabichromene (“CBC”) and is confident it can apply this manufacturing technology to create, at a larger scale, key rare cannabinoids, such as cannabidivarin (“CBDV”) and tetrahydrocannabivarin (“THCV”), on which it is currently focusing its attention. Earlier this year, InMed announced the launch of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector, marking the first of several new product launches planned for the first half of 2022 (https://ibn.fm/idE7P). For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• Investors are taking disparate approaches to gold as unusual inflation pressures raise questions about economic safeguards but the U.S. government continues to tout fiat strength amid employment positivity
• StraightUp Resources enters 2022 with a tailwind driving enthusiasm about its gold prospects in Ontario’s famed greenstone belt and a historically metal-rich region in the western United States
• In China, jewelry markets are beginning to recover from the COVID-19 pandemic’s darkest days, reporting a 44.99 percent year-over-year jump in consumer purchases of gold jewelry largely responsible for driving up the larger gold market
• StraightUp recently announced approval of an early exploration permit for a portion of its RLX North property, heralding activity this summer on the adjacent RLX North and RLX South exploration sites

Gold investment has become a betting man’s game as highest-in-a-generation inflation prompts renewed interest in the precious metal as a safe haven while governmental interest rate-boosting policies deflate the momentum toward non-interest yielding gold (https://ibn.fm/i8llv). While analysts generally expected that the COVID pandemic and world governments’ monetary stimulus response would induce inflation (https://ibn.fm/qbKaT), the U.S. Federal Reserve’s hawkish support of fiat currency by announcing proposed interest rate increases beginning in March has tempered interest in gold (https://ibn.fm/KOCZ6). Among the potential wildcards to be pulled from the deck: Gold is more than just an asset — the nearly indestructible metal has diverse uses, including in jewelry and technology (https://ibn.fm/BMoaX). Gold jewelry consumption fell precipitously during the early stages of the COVID-19 pandemic, but a nascent emergence from COVID’s darkest hours includes the recovery of the jewelry market as exemplified in recent news about the jump in gold consumption in China, led by rising jewelry purchases at a rate of 44.99 percent YOY and a 26.87 percent increase in gold bar and coin consumption (https://ibn.fm/0VOI2). Precious metals explorer and property asset class holder StraightUp Resources (CSE: ST) (OTCQB: STUPF) is bullish on the possibilities of its portfolio options and acquisitions in historically gold-and-silver rich regions. The Canada-headquartered mineral explorer has spent the last year steadily increasing its data on five gold properties it has optioned in Canada’s well-known greenstone belt in Ontario, as well as a gold and silver mine it acquired in the western United States. High-resolution heli-borne magnetic surveys (“MAGs”) and the subsequent ground investigation efforts at the Ontario Red Lake area properties have confirmed “multiple areas of high merit and potential mineralization” (https://ibn.fm/ByCxz) on one of the sites, known as the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres). On Jan. 13, the company announced approval of an early exploration permit for a portion of its RLX North property within the greenstone belt. The permit for mechanized drilling in the property’s eastern sector will be valid for three years, allowing StraightUp Resources to move forward with its 2022 work programs, which is expected to include drilling of the most prospective targets this summer, the company stated (https://ibn.fm/Alx4L). President Mark Brezer remarked that the company is in position to set up drill programs on both the RLX North property and the adjacent RLX South property, distinguished by changes in the underlying geology between each of them that are separated by two “metavolcanic packages” that StraightUp believes are highly prospective for economic deposits of gold. “The latest results, combined with our extensive data set from previous exploration, strengthen our commitment to the Red Lake Mining District and its potential for legendary, high-grade gold discoveries,” Brezer stated. “Local expertise is continuing to prove itself invaluable to our exploration goals.” StraightUp extended its investor reach in November by joining its Canadian Securities Exchange listing with a new listing on the OTCQB Venture Market in the United States. “I expect our shareholders to benefit through increases in trading liquidity and expanded retail and institutional investors,” Brezer said at the time (https://ibn.fm/K7vaL). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• As the number of older Americans moves to exceeding the number of children, analysts are forecasting the U.S. hearing aid market to grow 69% to $4.48 billion in 2028
• InnerScope Hearing Solutions is using a strong mix of Direct-to-Consumer and a retail footprint to market and sell its affordable, app-controlled hearing aids
• InnerScope recently acquired HearingAssist, making INND Walmart’s largest direct-ship and wholesale hearing aid supplier a two-prong stock purchase where the second leg gives INND a market cap of $1+ billion

Looking for overlooked market segments on Wall Street? Look to your elders. The U.S. Census Bureau (“USCB”) shows that the country is charting a course for older adults to outnumber kids for the first time ever. That means a growing number of cases of presbycusis, or age-related hearing loss. Luckily, today’s graying generation won’t have to use the bulky hearing aids of old; they can benefit from technological advancements from companies like InnerScope Hearing Technologies (OTC: INND) that make testing easier and hearing devices more discrete and affordable than ever before. Owing in part to younger generations having fewer children and people living longer, USCB sees the country reaching a milestone in 2034 when the number of people over age 65 outnumber those under age 18, approximately 77 million to 76.5 million. Data from the National Institute on Aging shows that about one in three people between the ages of 65 and 74 suffer from hearing loss, a figure that jumps to nearly 50 percent for people aged 75+. Against that backdrop, it’s not hard to understand why Fortune Business Insights forecasts the U.S. hearing aids market to grow 69% from $2.65 billion in 2021 to $4.48 billion in 2028. Other market research firms, including Allied Analytics and Market.us, see multiple drivers for continuous market expansion. InnerScope is on the leading edge of technology, delivering premium hearing products for lower prices, including app-controlled hearing aids (quick adjustments are made using a smartphone), hearing amplifiers, associated cleaning goods and vitamins through a direct-to-consumer (DTC) model that includes subscription plans so aging consumers don’t forget to order their goods. To get the process rolling, InnerScope offers a free online hearing test at www.MyHearIQ.com. The company also is establishing a strong brick-and-mortar retail presence. InnerScope’s wholly owned subsidiary, HearingAssist, is Walmart’s largest direct-ship and wholesale hearing aid supplier. InnerScope closed the acquisition of HearingAssist in late in November, bringing on board a company that has generated more than $72 million in revenue since 2018. InnerScope bought HearingAssist in an all-stock deal split into two price points for the stock, including the second tranche at $0.17 per share that equates to a market capitalization more than $1 billion. Last month, HearingAssist received purchase orders from Walmart totaling over $277,000 for its EZ-Hear Neckband Bluetooth Hearing Amplifier for in-store displays in 757 Walmart Stores across five states. Furthermore, InnerScope recently formed a partnership with grocery and pharmacy chain Giant Eagle. Per the deal, InnerScope’s automated self-check hearing screening kiosks are being installed in select Giant Eagle stores throughout Pennsylvania and Ohio. The Giant Eagle deployment was announced a week after InnerScope inked a deal with Food City Pharmacy to put the kiosks in three stores across Virginia and Tennessee, while incentivizing customers exclusive discounts for InnerScope products ordered through the Food City website. While it keeps churning out fundamental developments, the company recently took a moment to speak to investors with CEO Matthew Moore accepting an invitation to present at the Emerging Growth Conference earlier this month. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND